Showing 1 - 5 results of 5 for search 'Paola Torelli', query time: 0.03s Refine Results
  1. 1
    Antibiotic Exposure, Common Morbidities and Main Intestinal Microbial Groups in Very Preterm Neonates: A Pilot Study

    Antibiotic Exposure, Common Morbidities and Main Intestinal Microbial Groups in Very Preterm Neonates: A Pilot Study by Nicole Bozzi Cionci, Laura Lucaccioni, Elisa Pietrella, Monica Ficara, Caterina Spada, Paola Torelli, Luca Bedetti, Licia Lugli, Diana Di Gioia, Alberto Berardi

    Published 2022-02-01
    Get full text
    Article
  2. 2
    A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study

    A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study by Giulia Giannini, Giulia Giannini, Valentina Favoni, Elena Merli, Marianna Nicodemo, Paola Torelli, Annunzio Matrà, Carlo Maria Giovanardi, Pietro Cortelli, Pietro Cortelli, Giulia Pierangeli, Giulia Pierangeli, Sabina Cevoli

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients

    Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients by Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, Marco Aguggia, Renata Rao, Maurizio Zucco, Fabio Frediani, Massimo Filippi, Roberta Messina, Sabina Cevoli, Antonio Carnevale, Giulia Fiorentini, Stefano Messina, Francesco Bono, Paola Torelli, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri, for the Italian Migraine Registry study group

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study

    Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study by Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Paola Torelli, Cinzia Finocchi, Florindo d’Onofrio, Luigi d’Onofrio, Renata Rao, Stefano Messina, Laura Di Clemente, Angelo Ranieri, Massimo Autunno, Giuliano Sette, Bruno Colombo, Antonio Carnevale, Marco Aguggia, Miriam Tasillo, Francesco Zoroddu, Fabio Frediani, Massimo Filippi, Carlo Tomino, Stefania Proietti, Stefano Bonassi, for the FRIEND-Study Group

    Published 2023-03-01
    Get full text
    Article
  5. 5
    Corrigendum: Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects

    Corrigendum: Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects by Roberto Teggi, Bruno Colombo, Roberto Albera, Giacinto Asprella Libonati, Cristiano Balzanelli, Angel Batuecas Caletrio, Angel Batuecas Caletrio, Augusto P. Casani, Juan Manuel Espinosa-Sanchez, Juan Manuel Espinosa-Sanchez, Paolo Gamba, Jose A. Lopez-Escamez, Jose A. Lopez-Escamez, Sergio Lucisano, Marco Mandalà, Giampiero Neri, Daniele Nuti, Rudi Pecci, Antonio Russo, Eduardo Martin-Sanz, Ricardo Sanz, Gioacchino Tedeschi, Paola Torelli, Paolo Vannucchi, Giancarlo Comi, Mario Bussi

    Published 2020-01-01
    Get full text
    Article

Search Tools: